Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 10, 2020
NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice-Brief Report
Meritxell Nus, Gemma Basatemur, Maria Galan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 17, 2019
B Cell Fcγ Receptor IIb Modulates Atherosclerosis in Male and Female Mice by Controlling Adaptive Germinal Center and Innate B-1-Cell Responses
Jayashree Bagchi-Chakraborty, Anna Francis, Toni Bray, et al.
BMJ Open
|
February 27, 2024
Immune regulation and blood-brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study - a multicentre prospective cohort study
Audrey Low, Sanne van Winden, Lupei Cai, et al.
Nature Communications
|
June 8, 2017
Type-2 innate lymphoid cells control the development of atherosclerosis in mice
Stephen A Newland, Sarajo Mohanta, Marc Clément, et al.
Nature Medicine
|
April 18, 2017
Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet
Meritxell Nus, Andrew P Sage, Yuning Lu, et al.
Science Signaling
|
July 20, 2022
A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cells
Kristoffer H Johansen, Dominic P Golec, Bonnie Huang, et al.
Journal of the American College of Cardiology
|
September 10, 2021
Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction
Xian Yu, Stephen A Newland, Tian X Zhao, et al.
Cardiovascular Research
|
July 29, 2024
Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities
Andrej Ćorović, Xiaohui Zhao, Yuan Huang, et al.
Nature Medicine
|
January 8, 2026
Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial
Rouchelle S Sriranjan-Rothwell, Tian X Zhao, Stephen P Hoole, et al.
Cardiovascular Research
|
February 21, 2024
Marginal zone B cells produce 'natural' atheroprotective IgM antibodies in a T cell-dependent manner
James Harrison, Stephen A Newland, Wei Jiang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 10, 2020
NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice-Brief Report
Meritxell Nus, Gemma Basatemur, Maria Galan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 17, 2019
B Cell Fcγ Receptor IIb Modulates Atherosclerosis in Male and Female Mice by Controlling Adaptive Germinal Center and Innate B-1-Cell Responses
Jayashree Bagchi-Chakraborty, Anna Francis, Toni Bray, et al.
BMJ Open
|
February 27, 2024
Immune regulation and blood-brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study - a multicentre prospective cohort study
Audrey Low, Sanne van Winden, Lupei Cai, et al.
Nature Communications
|
June 8, 2017
Type-2 innate lymphoid cells control the development of atherosclerosis in mice
Stephen A Newland, Sarajo Mohanta, Marc Clément, et al.
Nature Medicine
|
April 18, 2017
Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet
Meritxell Nus, Andrew P Sage, Yuning Lu, et al.
Science Signaling
|
July 20, 2022
A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cells
Kristoffer H Johansen, Dominic P Golec, Bonnie Huang, et al.
Journal of the American College of Cardiology
|
September 10, 2021
Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction
Xian Yu, Stephen A Newland, Tian X Zhao, et al.
Cardiovascular Research
|
July 29, 2024
Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities
Andrej Ćorović, Xiaohui Zhao, Yuan Huang, et al.
Nature Medicine
|
January 8, 2026
Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial
Rouchelle S Sriranjan-Rothwell, Tian X Zhao, Stephen P Hoole, et al.
Cardiovascular Research
|
February 21, 2024
Marginal zone B cells produce 'natural' atheroprotective IgM antibodies in a T cell-dependent manner
James Harrison, Stephen A Newland, Wei Jiang, et al.
Page
of 4